S&P 500
(1.30%) 5 129.97 points
Dow Jones
(1.37%) 38 748 points
Nasdaq
(2.09%) 16 172 points
Oil
(-0.24%) $78.76
Gas
(0.59%) $2.05
Gold
(-0.67%) $2 294.20
Silver
(-1.06%) $26.55
Platinum
(0.41%) $966.50
USD/EUR
(-0.47%) $0.928
USD/NOK
(-1.37%) $10.84
USD/GBP
(-0.34%) $0.795
USD/RUB
(2.16%) $93.10

Actualizaciones en tiempo real para Perfect Holding SA [PRFN.SW]

Bolsa: SIX Industria: Transportation
Última actualización31 dic 1970 @ 19:00

-8.12% CHF 0.0362

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases...

Stats
Volumen de hoy 2.94M
Volumen promedio 859 130
Capitalización de mercado 0.00
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -36.20
ATR14 CHF0 (0.00%)

Perfect Holding SA Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Perfect Holding SA Finanzas

Annual 2021
Ingresos: CHF0.00
Beneficio Bruto: CHF0.00 (0.00 %)
EPS: CHF-0.000850
FY 2021
Ingresos: CHF0.00
Beneficio Bruto: CHF0.00 (0.00 %)
EPS: CHF-0.000850
FY 2020
Ingresos: CHF4.11M
Beneficio Bruto: CHF172 000 (4.19 %)
EPS: CHF-0.0000400
FY 2019
Ingresos: CHF17.30M
Beneficio Bruto: CHF552 000 (3.19 %)
EPS: CHF-0.00500

Financial Reports:

No articles found.

Perfect Holding SA

Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Its therapeutic drug candidate is KIN001, an advanced clinical stage p38 MAPK inhibitor combined with a marketed drug together enabling an oral long-term treatment for patients suffering from diseases. The company is based in Lausanne, Switzerland.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico